AHA Comments to FDA Re: Blood Glucose Monitoring Test Systems

AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.

View the following letter for details. 

Related Resources

Advancing Health Podcast
To Mitigate and Prevent: CommonSpirit Health's Transparent Culture and Error Reporting Toolkit
Public
Other Resources
Fellowship in Action | Next Generation Leaders Fellowship | Center
Leadership Rounds
Leadership Dialogue
Public
Advancing Health Podcast
What is Resilience Engineering and What Does it Mean for Patient Safety?
Public
Case Studies
AHA Value Initiative Members in Action: Rush University Medical Center – Chicago, IL
Other Resources
About the Climate and Community Health Initiative